Autoimmune liver diseases and inflammatory bowel diseases in children: current issues and future perspectives

Area of Science:

• Gastroenterology and Hepatology
• Pediatric Inflammatory Bowel Disease
• Hepatobiliary Manifestations

Background:

• Inflammatory bowel diseases (IBD) are chronic gut inflammation disorders with potential systemic effects.
• Extraintestinal manifestations occur in over 20% of pediatric IBD cases.
• Hepatobiliary involvement is frequent, with primary sclerosing cholangitis (PSC) affecting 6.4-7.8% of pediatric IBD patients.

Purpose of the Study:

• To review recent literature on hepatobiliary involvement in IBD patients.
• To focus on primary sclerosing cholangitis (PSC) in pediatric IBD.
• To provide updated information for diagnosis and management.

Main Methods:

• Literature review of recent studies on IBD and hepatobiliary manifestations.
• Analysis of data concerning primary sclerosing cholangitis (PSC) in pediatric IBD.
• Synthesis of current knowledge on diagnosis and management strategies.

Main Results:

• Hepatobiliary system involvement is a significant complication in IBD, particularly PSC in children.
• The pathogenesis of IBD-PSC linkage is multifactorial and not fully understood.
• Current therapeutic strategies for IBD-PSC are not standardized, with ongoing research into new medications.

Conclusions:

• The IBD-PSC association presents a unique model for studying disease mechanisms.
• Multidisciplinary approaches are essential for managing these complex patients.
• Further research is crucial to elucidate pathogenesis and improve patient care.